Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Fact Sheet
Feb 28, 2018
| Erica Klinger
Oppose Vermont House Bill 713
Blog
Feb 27, 2018
| Erik Komendant
The 180-Day Rule Supports Generic Competition. Here’s How.
Blog
Feb 23, 2018
| Rachel Schwartz
Recap of Access! 2018 — Chip's Call to Action (Part 2)
Fact Sheet
Feb 23, 2018
| Erica Klinger
Oppose Illinois House Bill 4900
Blog
Feb 19, 2018
| Rachel Schwartz
Recap of Access! 2018 — Successes From the Past Year (Part 1)
Press Release
Feb 12, 2018
| Rachel Schwartz
White Paper: Ensuring the Future of Accessible Medicines in the U.S.
Press Release
Feb 12, 2018
| Rachel Schwartz
AAM Announces 2018 Board of Directors
Report
Feb 12, 2018
| Erica Klinger
2017 AAM Annual Report
Report
Feb 9, 2018
| Erica Klinger
AAM White Paper: Ensuring the Future of Accessible Medicines in the U.S.
Press Release
Feb 6, 2018
| Rachel Schwartz
AAM and the Biosimilars Council Call on Congress to Increase Patient Access to Biosimilars
Blog
Feb 2, 2018
| Kristin Murphy
Help Pass the CREATES Act
Blog
Jan 31, 2018
| Erica Klinger
Dear Mr. President
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action